Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.
Identifieur interne : 000081 ( PubMed/Corpus ); précédent : 000080; suivant : 000082Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.
Auteurs : Luca Perico ; Ariela Benigni ; Giuseppe RemuzziSource :
- Nephron [ 2235-3186 ] ; 2020.
Abstract
Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.
DOI: 10.1159/000507305
PubMed: 32203970
Links to Exploration step
pubmed:32203970Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.</title>
<author><name sortKey="Perico, Luca" sort="Perico, Luca" uniqKey="Perico L" first="Luca" last="Perico">Luca Perico</name>
<affiliation><nlm:affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Benigni, Ariela" sort="Benigni, Ariela" uniqKey="Benigni A" first="Ariela" last="Benigni">Ariela Benigni</name>
<affiliation><nlm:affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Remuzzi, Giuseppe" sort="Remuzzi, Giuseppe" uniqKey="Remuzzi G" first="Giuseppe" last="Remuzzi">Giuseppe Remuzzi</name>
<affiliation><nlm:affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy, giuseppe.remuzzi@marionegri.it.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32203970</idno>
<idno type="pmid">32203970</idno>
<idno type="doi">10.1159/000507305</idno>
<idno type="wicri:Area/PubMed/Corpus">000081</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000081</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.</title>
<author><name sortKey="Perico, Luca" sort="Perico, Luca" uniqKey="Perico L" first="Luca" last="Perico">Luca Perico</name>
<affiliation><nlm:affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Benigni, Ariela" sort="Benigni, Ariela" uniqKey="Benigni A" first="Ariela" last="Benigni">Ariela Benigni</name>
<affiliation><nlm:affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Remuzzi, Giuseppe" sort="Remuzzi, Giuseppe" uniqKey="Remuzzi G" first="Giuseppe" last="Remuzzi">Giuseppe Remuzzi</name>
<affiliation><nlm:affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy, giuseppe.remuzzi@marionegri.it.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Nephron</title>
<idno type="eISSN">2235-3186</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32203970</PMID>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2235-3186</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Mar</Month>
<Day>23</Day>
</PubDate>
</JournalIssue>
<Title>Nephron</Title>
<ISOAbbreviation>Nephron</ISOAbbreviation>
</Journal>
<ArticleTitle>Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade.</ArticleTitle>
<Pagination><MedlinePgn>1-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1159/000507305</ELocationID>
<Abstract><AbstractText>Here, we review the most recent findings on the effects of SARS-CoV-2 infection on kidney diseases, including acute kidney injury, and examine the potential effects of ARBs on the outcomes of patients with COVID-19. Lastly, we discuss the clinical management of COVID-19 patients with existing chronic renal disorders, particularly those in dialysis and with kidney transplants.</AbstractText>
<CopyrightInformation>© 2020 S. Karger AG, Basel.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Perico</LastName>
<ForeName>Luca</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Benigni</LastName>
<ForeName>Ariela</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Remuzzi</LastName>
<ForeName>Giuseppe</ForeName>
<Initials>G</Initials>
<AffiliationInfo><Affiliation>Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy, giuseppe.remuzzi@marionegri.it.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy, giuseppe.remuzzi@marionegri.it.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>03</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Nephron</MedlineTA>
<NlmUniqueID>0331777</NlmUniqueID>
<ISSNLinking>1660-8151</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Angiotensin receptor blockers</Keyword>
<Keyword MajorTopicYN="N">Angiotensin-converting enzyme inhibitors</Keyword>
<Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Renal and cardiac side effects</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">Severe acute respiratory syndrome coronavirus</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>03</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>03</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32203970</ArticleId>
<ArticleId IdType="pii">000507305</ArticleId>
<ArticleId IdType="doi">10.1159/000507305</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000081 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000081 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV2 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:32203970 |texte= Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:32203970" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidV2
This area was generated with Dilib version V0.6.33. |